|Articles|December 5, 2018
PAREXEL Collaborates with Eli Lilly and Company
Advertisement
PAREXEL, an innovator of global biopharmaceutical services, announced a new collaboration with Eli Lilly and Company to launch a clinical research learning and development program in China which will bring training opportunities to China’s clinical trial sites and investigators.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves Subcutaneous Lunsumio VELO Based on GO29781 Trial Results in Relapsed or Refractory Follicular Lymphoma
2
Applying AI to Automate Workflows Without Disrupting Sites
3
ACT Brief: Building a Digital Thread in Life Sciences, CRO Sourcing Decisions and Site Burden, and Lilly’s Oral GLP-1 Phase III Results
4
Life Sciences Can’t Afford Fragmented Data and Disconnected Teams
5